SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 25.26 |
Enterprise Value ($M) | 5.46 |
Book Value ($M) | 28.40 |
Book Value / Share | 1.69 |
Price / Book | 0.89 |
NCAV ($M) | 9.31 |
NCAV / Share | 0.55 |
Price / NCAV | 2.71 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.72 |
Return on Assets (ROA) | -0.35 |
Return on Equity (ROE) | -0.68 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.94 |
Current Ratio | 5.94 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 46.60 |
Assets | 65.69 |
Liabilities | 37.29 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -39.06 |
Net Income | -39.86 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Alyeska Investment Group, L.P. | 9.99 | 18.17 | |
13G/A | Fmr Llc | 4.02 | -55.98 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,818 | 4,163 | 67.69 | |
3,946 | 28,482 | 13.85 | |
5,231 | 61,777 | 8.47 | |
9,456 | 35,729 | 26.47 | |
(click for more detail) |
Similar Companies | |
---|---|
TWST – Twist Bioscience Corporation | TXMD – TherapeuticsMD, Inc. |
TYRA – Tyra Biosciences, Inc. | UTHR – United Therapeutics Corporation |
VERV – Verve Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io